Loading...

Albert Labs International Corp.

ABRT.CNCNQ
Healthcare
Biotechnology
CA$0.005
CA$0.00(0.00%)

Albert Labs International Corp. (ABRT.CN) Stock Overview

Explore Albert Labs International Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.3/100

Key Financials

Market Cap372.1K
P/E Ratio-0.04
EPS (TTM)$-0.05
ROE16.27%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ABRT.CN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Albert Labs International Corp. (ABRT.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.04 and a market capitalization of 372.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;